ACH
ACCENDRA HEALTH INCPrice
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R May 11 Accendra Health entered into a comprehensive restructuring agreement…
- R May 11 Accendra Health reported Q1 2026 revenue of $627.8M (down 6.8% YoY f…
- R Aug 10 Accendra Health reported Q2 2026 revenue of $613.2M (down 10.1% YoY…
- A Aug 11 Citigroup downgrades
- X Aug 31 Short interest jumps 36.8% to 8.83M
- R Oct 9 Accendra Health received a delisting notice from the NYSE on October…
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- InstitutionsBULLISH
Q2 2026: 17 added (0 new), 10 trimmed or exited.
- AnalystsBEARISH
0 of 12 rate it Buy or better.
- Short sellersSTEADY
Short interest −5.3% to 8.42M shares. 4.9 days to cover, ≈10.9% of shares.
- TrendDOWNTREND
73% below its 50-day average. New closing low $0.2100 on Oct 22.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| MARSHALL WACE, LLP | ADD | $8.8M |
| DIMENSIONAL FUND ADVISORS LP | TRIM | $5.6M |
| TUDOR INVESTMENT CORP ET AL | DOUBLED | $1.9M |
| CITADEL ADVISORS LLC | ADD | $1.3M |
| MORGAN STANLEY | TRIM | $1.1M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | TRIM | $794.7K |
| MILLENNIUM MANAGEMENT LLC | TRIM | $690.9K |
| BNP PARIBAS FINANCIAL MARKETS | ADD | $546.1K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
12 analysts| Date | Firm | Rating |
|---|---|---|
| Aug 13, 2026 | UBS MAINTAIN | Neutral |
| Aug 11, 2026 | Citigroup DOWNGRADE | Neutral |
| Jul 24, 2026 | Citigroup MAINTAIN | Buy |
| May 12, 2026 | UBS MAINTAIN | Neutral |
| May 12, 2026 | Citigroup MAINTAIN | Buy |
| May 12, 2026 | Baird MAINTAIN | Outperform |
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Oct 5, 2026 | Gardner-Smith Kenneth President & CEO | AWARD | 283,554 sh |
| Sep 23, 2026 | Leon Jonathan A EVP & CFO | TAX W/H | $3.6K |
| May 18, 2026 | Galloway Heath H EVP,General Counsel & CorpSecy | TAX W/H | $5.3K |
| May 15, 2026 | Bernocchi Perry A EVP, Chief Operating Officer | TAX W/H | $24.0K |
| May 15, 2026 | Galloway Heath H EVP,General Counsel & CorpSecy | TAX W/H | $2.9K |
| May 15, 2026 | Pesicka Edward A President & CEO | TAX W/H | $53.8K |
| May 15, 2026 | Leon Jonathan A EVP & CFO | TAX W/H | $5.4K |
| May 14, 2026 | Beck Mark A Director | AWARD | 31,191 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data — subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data — subscribers only | |||
| Next Q | 🔒 Fresh data — subscribers only | |||
| Current FY | 🔒 Fresh data — subscribers only | |||
| Next FY | 🔒 Fresh data — subscribers only | |||
Short side
FINRA· Sep 30, 2026SecBot reports
15 filings · 1 bullish · 5 bearish · 1 mixed · 8 neutral- BEARISH 8-KOct 9, 2026
Accendra Health received a delisting notice from the NYSE on October 6, 2026, because its average…
Monitor the company's next quarterly filing for any revenue or earnings deterioration that could further pressure the stock price. The reverse stock split path, if pursued, is a mechanical fix that…
- NEUTRAL SC 13GOct 7, 2026
Bank of America Corp filed a Schedule 13G disclosing a passive 10.8% stake in Accendra Health Inc…
Bank of America's 10.8% passive stake signals institutional conviction but carries no activist intent. Monitor for any subsequent conversion to 13D or additional accumulation. The stake is large…
- NEUTRAL 8-KSep 17, 2026
Accendra Health announced a planned CEO transition, naming board member Kenneth Gardner-Smith as…
Monitor the Q4 2026 earnings call for Gardner-Smith's strategic priorities and any guidance updates under the new leadership team. The creation of a Chief Commercial Officer role signals a push for…
- BULLISH 8-KAug 17, 2026
Accendra Health filed an 8-K to announce it will not implement an ATM equity program (positive for…
The no-ATM decision and $45M non-core asset sale cash inflow are credit-positive signals that reduce equity dilution risk and strengthen the balance sheet. Monitor for the CEO successor announcement…
All ACH filing & press-release reports (15)
- 8-K reportOct 9, 2026
- SC 13G reportOct 7, 2026
- 8-K reportSep 17, 2026
- 8-K reportAug 17, 2026
- INST-CLUSTER reportAug 17, 2026
- 8-K reportAug 11, 2026
- 8-K reportAug 10, 2026
- 8-K reportAug 10, 2026
- EFFECT reportJul 27, 2026
- 8-K reportJun 26, 2026
- INST-CLUSTER reportJun 11, 2026
- 8-K reportMay 15, 2026
- 8-K reportMay 11, 2026
- 8-K reportMay 11, 2026
- DEFA14A reportApr 2, 2026